Minimizing reliance on animal testing in preclinical research is a critical ethical and scientific goal, and Certara software expertly supports this transition through advanced artificial intelligence-enabled biosimulation. By leveraging robust in silico physiologically-based pharmacokinetic models and virtual patient trials, the platform generates highly accurate, human-relevant insights that satisfy strict regulatory standards. These sophisticated tools empower researchers to identify safety risks earlier, simulate drug efficacy without animal subjects, and deliver robust mechanistic data for submissions. Ultimately, Certara helps biopharmaceutical organizations streamline development timelines, reduce ethical burdens, and accelerate innovative therapies to clinical trials with absolute

Join for free to read